Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 7 (2010), Issue 4 (April)

1. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma.
   J Surg Oncol, 101(5): 389-95. [Abstract] [Full-text]
2. Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.
   Prostate, 70(6): 616-29. [Abstract] [Full-text]
3. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
   Cancer Res, 70(7): 2819-28. [Abstract] [Full-text]
4. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
   Cancer Genet Cytogenet, 198(2): 97-106. [Abstract] [Full-text]
5. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.
   Gynecol Oncol, 117(2): 229-33. [Abstract] [Full-text]
6. Zygomatic intraosseous haemangioma: reconstruction with an alloplastic prosthesis based on a 3-D model.
   J Plast Reconstr Aesthet Surg, 63(5): e451-3. [Abstract] [Full-text]
7. Solitary intradural extramedullary lymphoma of the cervical spine.
   J Neurosurg Spine, 12(4): 436-9. [Abstract] [Full-text]
8. Image-guided, endoscopic, transcervical resection of cervical chordoma.
   J Neurosurg Spine, 12(4): 431-5. [Abstract] [Full-text]
9. Metastatic primary angiosarcoma of the breast in a pediatric patient with a complete response to systemic chemotherapy and definitive radiation therapy: case report and review of the literature.
   J Pediatr Hematol Oncol, 32(3): 192-4. [Abstract] [Full-text]
10. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy.
    Am J Clin Oncol, 33(2): 148-52. [Abstract] [Full-text]
11. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis.
    J Pathol, 221(1): 77-86. [Abstract] [Full-text]
12. A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss.
    Life Sci, 86(17): 646-53. [Abstract] [Full-text]
13. Preoperative transcatheter arterial embolization of hypervascular metastatic tumors of long bones.
    Acta Radiol, 51(4): 396-401. [Abstract] [Full-text]
14. Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells.
    Biochem Biophys Res Commun, 394(3): 715-20. [Abstract] [Full-text]
15. Mechanisms of breast cancer bone metastasis.
    Cancer Lett, 292(1): 1-7. [Abstract] [Full-text]
16. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
    Strahlenther Onkol, 186(4): 218-23. [Abstract] [Full-text]
17. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Genes Chromosomes Cancer, 49(6): 518-25. [Abstract] [Full-text]
18. Small cell osteosarcoma: cytopathologic characteristics and differential diagnosis.
    Am J Clin Pathol, 133(5): 756-61. [Abstract] [Full-text]
19. Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.
    Int J Radiat Oncol Biol Phys, 77(1): 217-25. [Abstract] [Full-text]
20. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
    Int J Radiat Oncol Biol Phys, 77(1): 86-91. [Abstract] [Full-text]
21. Three-dimensional reconstruction of a fibro-osseous lesion using binary images transformed from histopathological images.
    Dentomaxillofac Radiol, 39(4): 246-51. [Abstract] [Full-text]
22. Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment.
    J Surg Oncol, 101(6): 465-70. [Abstract] [Full-text]
23. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
    J Clin Oncol, 28(12): 1982-8. [Abstract] [Full-text]
24. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    J Clin Oncol, 28(12): 1989-94. [Abstract] [Full-text]
25. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Hum Pathol, 41(5): 653-62. [Abstract] [Full-text]
26. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Int J Cancer, 126(12): 2790-8. [Abstract] [Full-text]
27. Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
    Transl Res, 155(5): 247-55. [Abstract] [Full-text]
28. Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Pediatr Blood Cancer, 54(7): 1045-7. [Abstract] [Full-text]
29. Psychosocial and functional outcomes in long-term survivors of osteosarcoma: a comparison of limb-salvage surgery and amputation.
    Pediatr Blood Cancer, 54(7): 990-9. [Abstract] [Full-text]
30. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
    J Natl Cancer Inst, 102(8): 522-8. [Abstract] [Full-text]
31. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
    J Orthop Res, 28(6): 739-45. [Abstract] [Full-text]
32. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center.
    Cancer, 116(9): 2215-23. [Abstract] [Full-text]
33. Specific high-affinity binding of thiazole orange to triplex and G-quadruplex DNA.
    Biochemistry, 49(17): 3567-74. [Abstract] [Full-text]
34. Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer.
    Prostate, 70(8): 875-82. [Abstract] [Full-text]
35. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
    Br J Cancer, 102(9): 1319-26. [Abstract] [Full-text]
36. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
    Cancer Res, 70(9): 3494-504. [Abstract] [Full-text]

© 2004-2011 Bone Cancer Research Today. All Rights Reserved.